San Diego, CA, United States of America

Peter Olaf Arrhenius


Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Peter Olaf Arrhenius: Innovator in Fluorescence Immunoassays

Introduction

Peter Olaf Arrhenius is a notable inventor based in San Diego, CA. He has made significant contributions to the field of fluorescence immunoassays, holding a total of 3 patents. His work focuses on developing methods and compositions that enhance the accuracy and efficiency of biological fluid assays.

Latest Patents

Arrhenius's latest patents include innovative methods for fluorescence immunoassays that utilize fluorescent dyes free of aggregation and serum binding. These methods are particularly useful for analyzing biological fluids such as serum, plasma, whole blood, and urine. Another significant patent involves polyoxyhydrocarbyl related products and methods for fluorescence assays, which are suitable for applications in fluorescence immunoassays, in vivo imaging, and tumor therapy. His inventions also encompass compositions that link oligonucleotides to detectably labeled marker components, enhancing nucleic acid hybridization and amplification methods.

Career Highlights

Throughout his career, Arrhenius has worked with several companies, including Hyperion, Inc. and Diatron Corporation. His expertise in fluorescence technology has positioned him as a key player in the development of advanced diagnostic methods.

Collaborations

Arrhenius has collaborated with notable professionals in his field, including Robert F. Devlin and Walter B. Dandliker. These collaborations have contributed to the advancement of his innovative work in fluorescence immunoassays.

Conclusion

Peter Olaf Arrhenius is a distinguished inventor whose contributions to fluorescence immunoassays have significantly impacted the field of biological diagnostics. His innovative patents and collaborations continue to pave the way for advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…